Brief: Quince Therapeutics To Participate At A-T Society's 2025 A-T Clinical Research Conference
25/06/2025 22:03
June 25 (Reuters) - Quince Therapeutics Inc QNCX.O: QUINCE THERAPEUTICS TO PARTICIPATE AT A-T SOCIETY’S 2025 A-T CLINICAL RESEARCH CONFERENCE Source text: ID:nBw67SDw4a Further company coverage: QNCX.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges